Evogene is a computational biology company. Co.'s segments are: Agriculture, which includes its division and subsidiaries engaged in agricultural activities, including seed traits activity, ag-chemicals activity (through its subsidiary, AgPlenus Ltd.) and ag-biologicals activity (through its subsidiary, Lavie Bio Ltd.); Human Health, which focuses on discovery and development of human microbiome-based therapeutics (through its subsidiary, Biomica Ltd.) and cannabis activity (through its subsidiary, Canonic Ltd.); and Industrial applications, which focuses on the development and commercialization of improved castor bean seeds for industrial uses (through its subsidiary, Casterra Ag Ltd.). We show 10 historical shares outstanding datapoints in our coverage of EVGN's shares outstanding history.
Understanding the changing numbers of EVGN shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like EVGN versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching EVGN by allowing them to research EVGN shares outstanding history
as well as any other stock in our coverage universe. |
Free EVGN Email Alerts:
Video: Shares Outstanding Importance
